Back to Agenda
Session 5: Innovative approaches to integrated evidence
Session Chair(s)
Adrian Cassidy, PHD, MSC
Head Global Evidence Generation, Novartis, Switzerland
Michael Lees, MA
Chief Operating Officer and Head of Market Access Strategy, PHMR Ltd, United Kingdom
Session 5: Innovative Approaches to Integrated Evidence
Speaker(s)
Marcia Rueckbeil
Seconded National Expert (Data Analytics and Methods Task Force), European Medicines Agency, Netherlands
Real world evidence in marketing authorisation applications at EMA
Angela Ibald-Mulli, DrPH, MBA, MPH, MS
Integrated Evidence Generation Lead Thrombosis, Bayer Pharmaceuticals, Germany
Integrated Evidence Generation: The Innovation Challenge
Baris Erdogan, PHD
CEO, Clinerion Ltd, Switzerland
Accessing Multiple Patient Data Sources to Enhance Generation of Real-World Evidence, Outcome Research and Non-Research Evaluations
Ian Rentsch, JD
Executive Advisor, Remember the Girls, Germany
Accessing Multiple Patient Data Sources to Enhance Generation of Real-World Evidence, Outcome Research and Non-Research Evaluations
Have an account?